Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Preparing word cloud

×

Search

Type in a keyword to search

Filter by last modified time
See new records

Current Facets and Filters

  • Disease:Chronic myelogenous leukemia (facet)

Facets

Sort alphabetically | Sort by count

Recent searches

5,185 Results - per page

IDNameOrganismDiseaseCommentsProper CitationReferenceCategorySexSynonymsVendorCat NumCross ReferencesHierarchyOriginate from Same Individual
CVCL_8Z14KBM-7/B5-1803Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveGroup: Haploid karyotype cell line. Characteristics: Haploid except for a disomy of chromosome 8. Selected for resistance to: ChEBI; CHEBI:4027; Cyclophosphamide (CP; Endoxan). Derived from sampling site: Bone marrow. DT Created: 23-02-16; Last updated: 07-09-18; Version: 6RRID:CVCL_8Z14PMID:9783811Cancer cell line DT Created: 23-02-16; Last updated: 07-09-18; Version: 6DT Created: 23-02-16; Last updated: 07-09-18; Version: 6KBM7-B5-1803, KBM-7/B5 clone 1803 DT Created: 23-02-16, Last updated: 07-09-18, Version: 6Wikidata; Q54899588 DT Created: 23-02-16; Last updated: 07-09-18; Version: 6DT Created: 23-02-16; Last updated: 07-09-18; Version: 6DT Created: 23-02-16; Last updated: 07-09-18; Version: 6
CVCL_9119K562(S)Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSequence variation: BCR-ABL1 gene fusion (from parent cell line). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (from parent cell line). Derived from sampling site: Pleural effusion. DT Created: 06-06-12; Last updated: 05-07-19; Version: 11RRID:CVCL_9119PMID:6934848Cancer cell line DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12; Last updated: 05-07-19; Version: 11K-562 clone S, K-562, clone S DT Created: 06-06-12, Last updated: 05-07-19, Version: 11CLO; CLO_0007062 CLDB; cl2986 Wikidata; Q54899421 DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12; Last updated: 05-07-19; Version: 11
CVCL_9120K562(A)Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSequence variation: BCR-ABL1 gene fusion (from parent cell line). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (from parent cell line). Derived from sampling site: Pleural effusion. DT Created: 06-06-12; Last updated: 05-07-19; Version: 11RRID:CVCL_9120Cancer cell line DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12; Last updated: 05-07-19; Version: 11K-562 clone A, K-562, clone A DT Created: 06-06-12, Last updated: 05-07-19, Version: 11CLO; CLO_0007061 CLDB; cl2985 Wikidata; Q54899420 DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12; Last updated: 05-07-19; Version: 11
CVCL_9121K562-HHomo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSequence variation: BCR-ABL1 gene fusion (from parent cell line). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (from parent cell line). Derived from sampling site: Pleural effusion. DT Created: 06-06-12; Last updated: 05-07-19; Version: 11RRID:CVCL_9121PMID:7689892Cancer cell line DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12, Last updated: 05-07-19, Version: 11Wikidata; Q54899388 DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12; Last updated: 05-07-19; Version: 11
CVCL_9122K562-LHomo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSequence variation: BCR-ABL1 gene fusion (from parent cell line). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (from parent cell line). Derived from sampling site: Pleural effusion. DT Created: 06-06-12; Last updated: 05-07-19; Version: 11RRID:CVCL_9122PMID:7689892Cancer cell line DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12, Last updated: 05-07-19, Version: 11Wikidata; Q54899393 DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12; Last updated: 05-07-19; Version: 11DT Created: 06-06-12; Last updated: 05-07-19; Version: 11
CVCL_9478AR230Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveDerived from sampling site: Peripheral blood. DT Created: 06-06-12; Last updated: 07-09-18; Version: 7RRID:CVCL_9478PMID:7606740Cancer cell line DT Created: 06-06-12; Last updated: 07-09-18; Version: 7DT Created: 06-06-12; Last updated: 07-09-18; Version: 7AR-230 DT Created: 06-06-12, Last updated: 07-09-18, Version: 7Cosmic; 787490 Cosmic; 1026575 Cosmic; 2364007 Wikidata; Q54750353 DT Created: 06-06-12; Last updated: 07-09-18; Version: 7DT Created: 06-06-12; Last updated: 07-09-18; Version: 7DT Created: 06-06-12; Last updated: 07-09-18; Version: 7
CVCL_9492ERY-1Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveDoubling time: ~40 hours (PubMed=15475075). Derived from sampling site: Peripheral blood. DT Created: 06-06-12; Last updated: 07-09-18; Version: 7RRID:CVCL_9492PMID:15475075Cancer cell line DT Created: 06-06-12; Last updated: 07-09-18; Version: 7DT Created: 06-06-12; Last updated: 07-09-18; Version: 7DT Created: 06-06-12, Last updated: 07-09-18, Version: 7Wikidata; Q54832430 DT Created: 06-06-12; Last updated: 07-09-18; Version: 7DT Created: 06-06-12; Last updated: 07-09-18; Version: 7DT Created: 06-06-12; Last updated: 07-09-18; Version: 7
CVCL_9540LAMA-88Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSequence variation: BCR-ABL1 gene fusion (from parent cell line). Sequence variation: Homozygous for TP53 p.Lys319Ter (c.955A>T) (from parent cell line). Derived from sampling site: Peripheral blood. DT Created: 06-06-12; Last updated: 05-07-19; Version: 8RRID:CVCL_9540PMID:7996872Cancer cell line DT Created: 06-06-12; Last updated: 05-07-19; Version: 8DT Created: 06-06-12; Last updated: 05-07-19; Version: 8Lama-88, LAMA88 DT Created: 06-06-12, Last updated: 05-07-19, Version: 8Wikidata; Q54901916 DT Created: 06-06-12; Last updated: 05-07-19; Version: 8DT Created: 06-06-12; Last updated: 05-07-19; Version: 8DT Created: 06-06-12; Last updated: 05-07-19; Version: 8
CVCL_9V30KDI/20Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSelected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin). Sequence variation: BCR-ABL1 gene fusion (from parent cell line). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (from parent cell line). Derived from sampling site: Pleural effusion. DT Created: 23-02-16; Last updated: 05-07-19; Version: 7NCBI_Iran Cat# C637, RRID:CVCL_9V30PMID:17852455Cancer cell line DT Created: 23-02-16; Last updated: 05-07-19; Version: 7DT Created: 23-02-16; Last updated: 05-07-19; Version: 7DT Created: 23-02-16, Last updated: 05-07-19, Version: 7NCBI_IranC637NCBI_Iran; C637 Wikidata; Q54899708 DT Created: 23-02-16; Last updated: 05-07-19; Version: 7DT Created: 23-02-16; Last updated: 05-07-19; Version: 7DT Created: 23-02-16; Last updated: 05-07-19; Version: 7
CVCL_A052AP-217Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveDoubling time: 24-30 hours (PubMed=9279364). Derived from sampling site: Peripheral blood. DT Created: 06-06-12; Last updated: 05-07-19; Version: 9RRID:CVCL_A052References (2)Cancer cell line DT Created: 06-06-12; Last updated: 05-07-19; Version: 9DT Created: 06-06-12; Last updated: 05-07-19; Version: 9AP217 DT Created: 06-06-12, Last updated: 05-07-19, Version: 9Cosmic; 1012058 Wikidata; Q54750183 DT Created: 06-06-12; Last updated: 05-07-19; Version: 9DT Created: 06-06-12; Last updated: 05-07-19; Version: 9DT Created: 06-06-12; Last updated: 05-07-19; Version: 9
CVCL_A426KBM-7Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveGroup: Haploid karyotype cell line. Characteristics: Haploid except for a disomy of chromosome 8. Doubling time: 22 hours (PubMed=8609723). Omics: Deep exome analysis. Omics: Deep proteome analysis. Misspelling: KMB-7; Occasionally. Derived from sampling site: Bone marrow. DT Created: 06-06-12; Last updated: 14-05-18; Version: 14RRID:CVCL_A426References (4)Cancer cell line DT Created: 06-06-12; Last updated: 14-05-18; Version: 14DT Created: 06-06-12; Last updated: 14-05-18; Version: 14KBM7, KBM-7/Hap8 DT Created: 06-06-12, Last updated: 14-05-18, Version: 14BTO; BTO:0005775 EFO; EFO_0005903 4DN; 4DNSRYBIH9HS BioSample; SAMN03473259 Cosmic; 787496 ENCODE; ENCBS322FGS ENCODE; ENCBS815EDC Wikidata; Q18392835 DT Created: 06-06-12; Last updated: 14-05-18; Version: 14DT Created: 06-06-12; Last updated: 14-05-18; Version: 14DT Created: 06-06-12; Last updated: 14-05-18; Version: 14
CVCL_A682SS9;22Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveDT Created: 06-06-12; Last updated: 07-09-18; Version: 4RRID:CVCL_A682PMID:23955599Cancer cell line DT Created: 06-06-12; Last updated: 07-09-18; Version: 4DT Created: 06-06-12; Last updated: 07-09-18; Version: 4SS9:22, SS9-22, SS 9:22 DT Created: 06-06-12, Last updated: 07-09-18, Version: 4CGH-DB; 9217-4 Cosmic; 998759 Cosmic; 1037679 Cosmic; 2089674 Wikidata; Q54955687 DT Created: 06-06-12; Last updated: 07-09-18; Version: 4DT Created: 06-06-12; Last updated: 07-09-18; Version: 4DT Created: 06-06-12; Last updated: 07-09-18; Version: 4
CVCL_A691TS9;22Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSequence variation: Homozygous for ASXL1 p.Arg693Ter (c.2077C>T). Derived from sampling site: Peripheral blood. DT Created: 06-06-12; Last updated: 07-09-18; Version: 9RRID:CVCL_A691References (4)Cancer cell line DT Created: 06-06-12; Last updated: 07-09-18; Version: 9DT Created: 06-06-12; Last updated: 07-09-18; Version: 9TS9:22, TS9-22, TS 9:22 DT Created: 06-06-12, Last updated: 07-09-18, Version: 9CGH-DB; 9347-4 Cosmic; 996326 Cosmic; 998758 Cosmic; 1012126 Cosmic; 1037678 Cosmic; 2089678 Wikidata; Q54973096 DT Created: 06-06-12; Last updated: 07-09-18; Version: 9DT Created: 06-06-12; Last updated: 07-09-18; Version: 9DT Created: 06-06-12; Last updated: 07-09-18; Version: 9
CVCL_A743YS9;22Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveDerived from sampling site: Peripheral blood. DT Created: 06-06-12; Last updated: 07-09-18; Version: 8RRID:CVCL_A743References (2)Cancer cell line DT Created: 06-06-12; Last updated: 07-09-18; Version: 8DT Created: 06-06-12; Last updated: 07-09-18; Version: 8YS9:22, YS9-22, YS 9:22 DT Created: 06-06-12, Last updated: 07-09-18, Version: 8CGH-DB; 9220-4 Cosmic; 1012129 Wikidata; Q54995518 DT Created: 06-06-12; Last updated: 07-09-18; Version: 8DT Created: 06-06-12; Last updated: 07-09-18; Version: 8DT Created: 06-06-12; Last updated: 07-09-18; Version: 8
CVCL_AE17LAMA84RHomo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSelected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571). Sequence variation: BCR-ABL1 gene fusion (from parent cell line). Sequence variation: Homozygous for TP53 p.Lys319Ter (c.955A>T) (from parent cell line). Derived from sampling site: Peripheral blood. DT Created: 23-02-16; Last updated: 05-07-19; Version: 5RRID:CVCL_AE17PMID:10688835Cancer cell line DT Created: 23-02-16; Last updated: 05-07-19; Version: 5DT Created: 23-02-16; Last updated: 05-07-19; Version: 5LAMA84-R DT Created: 23-02-16, Last updated: 05-07-19, Version: 5Wikidata; Q54901919 DT Created: 23-02-16; Last updated: 05-07-19; Version: 5DT Created: 23-02-16; Last updated: 05-07-19; Version: 5DT Created: 23-02-16; Last updated: 05-07-19; Version: 5
CVCL_AW13K562 eGFP-ATF1Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSequence variation: BCR-ABL1 gene fusion (from parent cell line). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (from parent cell line). Transfected with: HGNC; 783; ATF1. Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP). Derived from sampling site: Pleural effusion. DT Created: 02-05-16; Last updated: 05-07-19; Version: 7RRID:CVCL_AW13Cancer cell line DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16, Last updated: 05-07-19, Version: 7ENCODE; ENCBS377AAA ENCODE; ENCBS405AAA ENCODE; ENCBS821FOP Wikidata; Q54899297 DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16; Last updated: 05-07-19; Version: 7
CVCL_AW14K562 eGFP-BACH1Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSequence variation: BCR-ABL1 gene fusion (from parent cell line). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (from parent cell line). Transfected with: HGNC; 935; BACH1. Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP). Derived from sampling site: Pleural effusion. DT Created: 02-05-16; Last updated: 05-07-19; Version: 8RRID:CVCL_AW14Cancer cell line DT Created: 02-05-16; Last updated: 05-07-19; Version: 8DT Created: 02-05-16; Last updated: 05-07-19; Version: 8DT Created: 02-05-16, Last updated: 05-07-19, Version: 8ENCODE; ENCBS024CCL ENCODE; ENCBS083LQN ENCODE; ENCBS706JJD ENCODE; ENCBS746PBJ Wikidata; Q54899300 DT Created: 02-05-16; Last updated: 05-07-19; Version: 8DT Created: 02-05-16; Last updated: 05-07-19; Version: 8DT Created: 02-05-16; Last updated: 05-07-19; Version: 8
CVCL_AW15K562 eGFP-CEBPBHomo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSequence variation: BCR-ABL1 gene fusion (from parent cell line). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (from parent cell line). Transfected with: HGNC; 1834; CEBPB. Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP). Derived from sampling site: Pleural effusion. DT Created: 02-05-16; Last updated: 05-07-19; Version: 7RRID:CVCL_AW15Cancer cell line DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16, Last updated: 05-07-19, Version: 7ENCODE; ENCBS378AAA ENCODE; ENCBS406AAA ENCODE; ENCBS818FPM Wikidata; Q54899301 DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16; Last updated: 05-07-19; Version: 7
CVCL_AW16K562 eGFP-CREB3Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSequence variation: BCR-ABL1 gene fusion (from parent cell line). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (from parent cell line). Transfected with: HGNC; 2347; CREB3. Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP). Derived from sampling site: Pleural effusion. DT Created: 02-05-16; Last updated: 05-07-19; Version: 7RRID:CVCL_AW16Cancer cell line DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16, Last updated: 05-07-19, Version: 7ENCODE; ENCBS312MPK ENCODE; ENCBS411NIF ENCODE; ENCBS753IIO Wikidata; Q54899304 DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16; Last updated: 05-07-19; Version: 7
CVCL_AW17K562 eGFP-DDX20Homo sapiensChronic myelogenous leukemia, BCR-ABL1 positiveSequence variation: BCR-ABL1 gene fusion (from parent cell line). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (from parent cell line). Transfected with: HGNC; 2743; DDX20. Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP). Derived from sampling site: Pleural effusion. DT Created: 02-05-16; Last updated: 05-07-19; Version: 7RRID:CVCL_AW17Cancer cell line DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16, Last updated: 05-07-19, Version: 7ENCODE; ENCBS026JDH ENCODE; ENCBS196WDN ENCODE; ENCBS216ZMH Wikidata; Q54899306 DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16; Last updated: 05-07-19; Version: 7DT Created: 02-05-16; Last updated: 05-07-19; Version: 7
X
  1. RRID Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  6. Facets

    Here are the facets that you can filter the data by.

  7. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.